Siphonaxanthin, a marine carotenoid from green algae, effectively induces apoptosis in human leukemia (HL-60) cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1810, Issue 5, 2011, Pages 497-503

  Ganesan, Ponesakki ^a   Noda, Kenji ^a   Manabe, Yuki ^a   Ohkubo, Takeshi ^b   Tanaka, Yukihisa ^b   Maoka, Takashi ^c   Sugawara, Tatsuya ^a   Hirata, Takashi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NOF Corporation   (Japan)

^c RESEARCH INSTITUTE FOR PRODUCTION DEVELOPMENT   (Japan)

Author keywords

Apoptosis; Carotenoid; Fucoxanthin; HL 60; Siphonaxanthin

Indexed keywords

ASTAXANTHIN; CAROTENOID; CASPASE 3; DEATH RECEPTOR 5; FUCOXANTHIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45 ALPHA; MESSENGER RNA; NEOXANTHIN; PROTEIN BCL 2; SIPHONAXANTHIN; UNCLASSIFIED DRUG; VIOLAXANTHIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CAROTENOIDS; CELL CYCLE PROTEINS; CELL SURVIVAL; CHLOROPHYTA; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HL-60 CELLS; HUMANS; IN SITU NICK-END LABELING; LEUKEMIA, PROMYELOCYTIC, ACUTE; MARINE BIOLOGY; MOLECULAR STRUCTURE; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; XANTHOPHYLLS;

CHLOROPHYTA;

EID: 79952697175     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.02.008     Document Type: Article

References (37)

1. B. Jansen, V. Wacheck, E. Heere-Ress, H. Schlagbauer-Wadl, C. Hoeller, T. Lucas, M. Hoermann, U. Hollenstein, K. Wolff, H. Pehamberger, Chemosensitisation of malignant melanoma by Bcl-2 antisense therapy, Lancet 356 (2000) 1728-1733.
2. G.V. Labi, F. Grespi, F. Baumer, A. Villunger, Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy? Cell Death Differ. 15 (2008) 977-987.
3. A. Ashkenazi, R.S. Herbst, To kill a tumour cell: the potential of proapoptotic receptor agonists, J. Clin. Invest. 118 (2008) 1979-1990.
4. F.A. Grecoa, P. Bonomi, J. Crawford, K. Kelly, Y. Oh, W. Halpern, L. Lo, G. Gallant, J. Klein, Phase-2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer, Lung Cancer 61 (2008) 82-90.
5. T. Ohmori, E.R. Podack, K. Nishio, M. Takahashi, Y. Miyahara, Y. Takeda, N. Kubota, Y. Funayama, H. Ogasawara, T. Ohira, S. Ohta, N. Saijo, Apoptosis of lung cancer cells caused by some anti-cancer agents (MMC, CPT-11, ADM) is inhibited by Bcl-2, Biochem. Biophys. Res. Commun. 192 (1993) 30-36. (Pubitemid 23205264)
6. R.S. Gunasekara, K. Sewgobind, S. Desai, L. Dunn, H.S. Black, W.L. McKeehan, B. Patil, Lycopene and lutein inhibit proliferation in rat prostate carcinoma cells, Nutr. Cancer 58 (2007) 171-177. (Pubitemid 47333827)
7. F. Meyer, I. Bairati, E. Jobin, M. Gelinas, A. Fortin, A. Nabid, B. Tetu, Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients, Nutr. Cancer 59 (2007) 29-35. (Pubitemid 47549778)
8. U. Peters, M.F. Leitzmann, N. Chatterjee, Y. Wang, D. Albanes, E.P. Gelmann, M.D. Friesen, E. Riboli, R.B. Hayes, Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial, Cancer Epidemiol. Biomark. Prev. 16 (2007) 962-968.
9. K.R. Upadhyaya, K.S. Radha, H.K. Madhyastha, Cell cycle regulation and induction of apoptosis by beta carotene in U937 and HL-60 leukemia cells, J. Biochem. Mol. Biol. 40 (2007) 1009-1015. (Pubitemid 350242288)
10. H. Nishino, M. Murakoshi, H. Tokuda, Y. Satomi, Cancer prevention by carotenoids, Arch. Biochem. Biophys. 483 (2009) 165-168.
11. E. Giovannucci, A. Ascherio, E.B. Rimm, M.J. Stampfer, G.A. Colditz, W.C. Willett, Intake of carotenoids and retinol in relation to risk of prostate cancer, J. Natl Cancer Inst. 87 (1995) 1767-1776.
12. E. Giovannucci, A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer, Exp. Biol. Med. 227 (2002) 852-859.
13. E. Kotake-Nara, M. Kushiro, H. Zhang, T. Sugawara, K. Miyashita, A. Nagao, Carotenoids affect proliferation of human prostate cancer cells, J. Nutr. 131 (2001) 3303-3306. (Pubitemid 33136153)
14. M. Hosokawa, S. Wanezaki, K. Miyauchi, H. Kurihara, H. Kohno, J. Kawabata, S. Odashima, K. Takahashi, Apoptosis-inducing effect of fucoxanthin on human leukemia cell line HL-60, Food Sci. Technol. Res. 5 (1999) 243-246. (Pubitemid 129607585)
15. M. Hosokawa, M. Kudo, H. Maeda, H. Kohno, T. Tanaka, K. Miyashita, Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARγ ligand, troglitazone, on colon cancer cells, Biochim. Biophys. Acta 1675 (2004) 113-119. (Pubitemid 39463260)
16. E. Kotake-Nara, A. Asai, A. Nagao, Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells, Cancer Lett. 220 (2005) 75-84. (Pubitemid 40312020)
17. I. Konishi, M. Hosokawa, T. Sashima, H. Kobayashi, K. Miyashita, Halocynthiaxanthin and fucoxanthinol isolated from Halocynthia roretzi induce apoptosis in human leukemia, breast and colon cancer cells, Comp. Biochem. Physiol. C 142 (2006) 53-59.
18. T. Sugawara, K. Yamashita, S. Sakai, A. Asai, A. Nagao, T. Shiraishi, I. Imai, T. Hirata, Induction of apoptosis in DLD-1 human colon cancer cells by peridinin isolated from the dinoflagellate, Heterocapsa triguetra, Biosci. Biotechnol. Biochem. 71 (2007) 1069-1072.
19. T. Sugawara, M. Kushiro, H. Zhang, E. Nara, H. Ono, A. Nagao, Lysophosphatidylcholine enhances carotenoid uptake from mixed micelles by Caco-2 human intestinal cells, J. Nutr. 131 (2001) 2921-2927. (Pubitemid 33063124)
20. T. Sugawara, V. Baskaran, W. Tsuzuki, A. Nagao, Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice, J. Nutr. 132 (2002) 946-951. (Pubitemid 34493558)
21. T. Sugawara, K. Yamashita, A. Asai, A. Nagao, T. Shiraishi, I. Imai, T. Hirata, Esterification of xanthophylls by human intestinal Caco-2 cells, Arch. Biochem. Biophys. 483 (2009) 205-212.
22. P. Ganesan, K. Matsubara, T. Ohkubo, Y. Tanaka, K. Noda, T. Sugawara, T. Hirata, Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile, Phytomed. 17 (2010) 1140-1144.
23. Y. Yoshii, S. Takaichi, T. Maoka, S. Hanada, I. Inouye, Characterization of two unique carotenoids fatty acid esters from Pterosperma cristatum (Prasinophyceae, Chlorophyta), J. Phycol. 38 (2002) 297-303. (Pubitemid 34439735)
24. Y. Gavrieli, Y. Sherman, S.A. Ben-Sasson, Identification of programmed cell death in situ via specific labeling DNA fragmentation, J. Cell Biol. 119 (1992) 493-502.
25. M. Harada-Shiba, M. Kinoshita, H. Kamido, K. Shimokado, Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms, J. Biol. Chem. 273 (1998) 9681-9687.
26. A. Asai, T. Sugawara, H. Ono, A. Nagao, Biotransformation of fucoxanthinol to amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites, Drug Metab. Dispos. 32 (2004) 205-211.
27. E. Kotake-Nara, T. Sugawara, A. Nagao, Antiproliferative effect of neoxanthin and fucoxanthin on cultured cells, Fish. Sci. 71 (2005) 459-461.
28. C. Ishikawa, S. Tafuku, T. Kadekaru, S. Sawada, M. Tomita, T. Okudaira, T. Nakazato, T. Toda, J. Uchihara, N. Taira, K. Ohshiro, T. Yasumoto, T. Ohta, N. Mori, Antiadult T-cell leukemia effect of brown algae fucoxanthin and its deacetylated product, fucoxanthinol, Int. J. Cancer 123 (2008) 2702-2712.
29. P. Palozza, N. Maggiano, G. Calviello, P. Lanza, E. Piccioni, F.O. Ranelletti, G.M. Bartoli, Canthaxanthin induces apoptosis in human cancer cell lines, Carcinogenesis 19 (1998) 373-376. (Pubitemid 28375436)
30. P.E. Bowen, S.M. Herbst-Espinosa, E.A. Hussain, M. Stacewicz-Sapuntzakis, Esterification does not impair lutein bioavailability in humans, J. Nutr. 132 (2002) 3668-3673. (Pubitemid 35435045)
31. D.E. Breithaupt, P. Weller, M. Wolters, A. Hahn, Plasma response to a single dose of dietary β-cryptoxanthin esters from papaya (Carica papaya L) or non-esterified β-cryptoxanthin in adult human subjects: a comparative study, Br. J. Nutr. 90 (2003) 795-801.
32. D.E. Breithaupt, P. Weller, M. Wolters, A. Hahn, Comparison of plasma responses in human subjects after the ingestion of 3R,3R′-zeaxanthin dipalmitate from wolfberry (Lycium barbarum) and non-esterified 3R,3R′-zeaxanthin using chiral high-performance liquid chromatography, Br. J. Nutr. 91 (2004) 707-713.
33. S. Yoshiko, N. Hoyoku, Fucoxanthin, a natural carotenoid, induces G1 arrest and GADD45 gene expression in human cancer cells, In Vivo 21 (2007) 305-310.
34. R.K. Srivastava, TRAIL/Apo-2L: mechanisms and clinical applications in cancer, Neoplasia 3 (2001) 535-546. (Pubitemid 33151020)
35. X. Gao, D. Deeb, H. Jiang, Y.B. Liu, S.A. Dulchavsky, S.C. Gautam, Curcum indifferentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria, J. Exp. Ther. Oncol. 5 (2005) 39-48. (Pubitemid 41076989)
36. R. Shi, C. Ong, H. Shen, Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells, Cancer Res. 65 (2005) 7815-7823. (Pubitemid 41297257)
37. T. Yoshida, T. Maoka, S.K. Das, K. Kanazawa, M. Horinaka, M. Wakada, Y. Satomi, H. Nishino, T. Sakai, Halocynthiaxanthin and peridinin sensitize colon cancer cell lines to tumor necrosis factor-related apoptosis-inducing ligand, Mol. Cancer Res. 5 (2007) 615-625.